AZD-1480 | m-entrepreneurship.com

Product Name :
AZD-1480

Search keywords :
AZD-1480

drugId :
null

Target Vo:
Tyrosine-protein kinase JAK2

Target Vo Short Name :
JAK2

Moa_Name:
Tyrosine-protein kinase JAK2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Astrazeneca Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Hepatocellular

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Smad1 (Ser463/Ser465) Rabbit mAb Autophagy
Racotumomab Technical Information
ERK5 Antibody: ERK5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 115 kDa, targeting to ERK5. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts